4-Hydroxy-4-(3-(2-naphthyl)propyl)piperidine → 2-(r)-(3-(s)-((4-Hydroxy-4-(3-(2-napthyl)propyl)piperidin-1-yl)methyl)-4-(s)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid

HRID 1386729Notes

Reaction equation

HRID 1386729 reaction equation
[CH:1]([C@@H:3]1[C@@H:7]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH2:6][N:5]([C@H:14]([CH:25]2[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]2)[C:15]([O:17]CC2C=CC=CC=2)=[O:16])[CH2:4]1)=O.[OH:31][C:32]1([CH2:38][CH2:39][CH2:40][C:41]2[CH:50]=[CH:49][C:48]3[C:43](=[CH:44][CH:45]=[CH:46][CH:47]=3)[CH:42]=2)[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]1>>[OH:31][C:32]1([CH2:38][CH2:39][CH2:40][C:41]2[CH:50]=[CH:49][C:48]3[C:43](=[CH:44][CH:45]=[CH:46][CH:47]=3)[CH:42]=2)[CH2:33][CH2:34][N:35]([CH2:1][C@@H:3]2[C@@H:7]([C:8]3[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=3)[CH2:6][N:5]([C@H:14]([CH:25]3[CH2:26][CH2:27][CH2:28][CH2:29][CH2:30]3)[C:15]([OH:17])=[O:16])[CH2:4]2)[CH2:36][CH2:37]1

Participants

3

Reactant 2

HCID 211807754-Hydroxy-4-(3-(2-naphthyl)propyl)piperidine2×HCID 599246172-(R)-(3-(R)-formyl-4-(S)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid, benzyl ester

Product 1

HCID 206724042-(r)-(3-(s)-((4-Hydroxy-4-(3-(2-napthyl)propyl)piperidin-1-yl)methyl)-4-(s)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid

Procedure

The title compound was prepared from 2-(R)-(3-(R)-formyl-4-(S)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid, benzyl ester (from EXAMPLE 1, Step I) and 4-hydroxy-4-(3-(2-naphthyl)propyl)piperidine.HCl (from EXAMPLE 82, Step A) using procedures analogous to those described in EXAMPLE 71, Steps A and B. For the title compound: 1H NMR (500 MHz) δ 0.89-3.88 (35H), 7.22-7.77 (12H); ESI-MS 569.6 (M+H).

Sources & evidence

ORD record
ord-a8e60f58a9844f4fb30342c13c242214
Source dataset
uspto-grants-2001_07
Patent number
US06265434B1

Reaction notes

Loading…